Skip to main content
Top
Literature
1.
go back to reference Lambrecht RM. Positron emitting radionuclides-present and future status. Proceedings second international symposium on radiopharmaceuticals. 19–22 March 1979 Seattle, Washington. The Society of Nuclear Medicine Inc., New york. Lambrecht RM. Positron emitting radionuclides-present and future status. Proceedings second international symposium on radiopharmaceuticals. 19–22 March 1979 Seattle, Washington. The Society of Nuclear Medicine Inc., New york.
2.
go back to reference Qaim SM. Cyclotron production of generator radionuclides. Radiochim Acta. 1987;41:111–7. Qaim SM. Cyclotron production of generator radionuclides. Radiochim Acta. 1987;41:111–7.
3.
go back to reference Mirzadeh S, Knapp FF Jr. Biomedical radioisotope generator systems. J Radioanal Nucl Chem. 1996;303:471–88. Mirzadeh S, Knapp FF Jr. Biomedical radioisotope generator systems. J Radioanal Nucl Chem. 1996;303:471–88.
4.
go back to reference Verel I, Visser GWM, Boerman OC, van Eerd JEM, Finn R, Boellaard R, et al. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. Cancer Biother Radiopharm. 2003;18(4):655–61.PubMedCrossRef Verel I, Visser GWM, Boerman OC, van Eerd JEM, Finn R, Boellaard R, et al. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. Cancer Biother Radiopharm. 2003;18(4):655–61.PubMedCrossRef
5.
go back to reference Green MA, Welch MJ. Gallium radiopharmaceutical chemistry. Nucl Med Biol. 1989;16(5):435–48. Green MA, Welch MJ. Gallium radiopharmaceutical chemistry. Nucl Med Biol. 1989;16(5):435–48.
6.
go back to reference Lewis MR, Reichert DE, Laforest R, Margenau WH, Shefer RE, Klinkowstein RE, et al. Production and purification of Gallium-66 for preparation of tumor targeting radiopharmaceuticals. Nucl Med Biol. 2002;29:701–6.PubMedCrossRef Lewis MR, Reichert DE, Laforest R, Margenau WH, Shefer RE, Klinkowstein RE, et al. Production and purification of Gallium-66 for preparation of tumor targeting radiopharmaceuticals. Nucl Med Biol. 2002;29:701–6.PubMedCrossRef
7.
go back to reference Palumbo B, Sivolella S, Palumbo I, Liberati AM, Palumbo R. 67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma. Eur J Nucl Med Mol Imaging. 2005;32:1011–7.PubMedCrossRef Palumbo B, Sivolella S, Palumbo I, Liberati AM, Palumbo R. 67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma. Eur J Nucl Med Mol Imaging. 2005;32:1011–7.PubMedCrossRef
8.
go back to reference Breeman WAP, Verbruggen AM. The 68Ge/68Ga generator has high potential, but when can we use 68 Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 2007;34:978–981. Breeman WAP, Verbruggen AM. The 68Ge/68Ga generator has high potential, but when can we use 68 Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 2007;34:978–981.
9.
go back to reference Bokhari TH, Mushtaq A, Khan IU. Concentration of 68Ga via solvent extraction. Appl Radiat Isotop. 2009;67:100–2.CrossRef Bokhari TH, Mushtaq A, Khan IU. Concentration of 68Ga via solvent extraction. Appl Radiat Isotop. 2009;67:100–2.CrossRef
Metadata
Title
PET without cyclotron
Author
Ahmad Mushtaq
Publication date
01-05-2009
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 3/2009
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-009-0231-y

Other articles of this Issue 3/2009

Annals of Nuclear Medicine 3/2009 Go to the issue